1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Global Bioengineered Protein Drugs Industry 2015 Market Research Report

Summary


The Global Bioengineered Protein Drugs Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Bioengineered Protein Drugs industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Bioengineered Protein Drugs market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.The Bioengineered Protein Drugs industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 310 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

Global Bioengineered Protein Drugs Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Bioengineered Protein Drugs
1.2 Classification of Bioengineered Protein Drugs
1.3 Applications of Bioengineered Protein Drugs
1.4 Industry Chain Structure of Bioengineered Protein Drugs
1.5 Industry Regional Overview of Bioengineered Protein Drugs
1.6 Industry Policy Analysis of Bioengineered Protein Drugs
1.7 Industry News Analysis of Bioengineered Protein Drugs

2 Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs
2.1 Raw Material Suppliers and Price Analysis of Bioengineered Protein Drugs
2.2 Equipment Suppliers and Price Analysis of Bioengineered Protein Drugs
2.3 Labor Cost Analysis of Bioengineered Protein Drugs
2.4 Other Costs Analysis of Bioengineered Protein Drugs
2.5 Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs
2.6 Manufacturing Process Analysis of Bioengineered Protein Drugs

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of Global Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of Global Key Bioengineered Protein Drugs Manufacturers in 2014
3.3 RandD Status and Technology Source of Global Bioengineered Protein Drugs Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of Global Bioengineered Protein Drugs Key Manufacturers in 2014

4 Production Analysis of Bioengineered Protein Drugs by Regions, Technology, and Applications
4.1 Global Production of Bioengineered Protein Drugs by Regions (US, EU, China, Japan, etc.) 2010-2015
4.2 Global Production of Bioengineered Protein Drugs by Technology 2010-2015
4.3 Global Production of Bioengineered Protein Drugs by Applications 2010-2015
4.4 Price Analysis of Global Bioengineered Protein Drugs Key Manufacturers in 2015
4.5 US Capacity, Production, Price, Cost and Revenue of Bioengineered Protein Drugs 2010-2015
4.6 EU Capacity, Production, Price, Cost and Revenue of Bioengineered Protein Drugs 2010-2015
4.7 Japan Capacity, Production, Price, Cost and Revenue of Bioengineered Protein Drugs 2010-2015
4.8 China Capacity, Production, Price, Cost and Revenue of Bioengineered Protein Drugs 2010-2015
4.9 US Supply, Import, Export and Consumption of Bioengineered Protein Drugs 2010-2015
4.10 EU Supply, Import, Export and Consumption of Bioengineered Protein Drugs 2010-2015
4.11 Japan Supply, Import, Export and Consumption of Bioengineered Protein Drugs 2010-2015
4.12 China Supply, Import, Export and Consumption of Bioengineered Protein Drugs 2010-2015

5 Sales and Revenue Analysis of Bioengineered Protein Drugs by Regions
5.1 Global Sales of Bioengineered Protein Drugs by Regions (US, EU, China, Japan, etc.) 2010-2015
5.2 Global Revenue of Bioengineered Protein Drugs by Regions (US, EU, China, Japan, etc.) 2010-2015
5.3 Global Price Analysis of Bioengineered Protein Drugs Sales by Regions (US, EU, China, Japan, etc.) 2010-2015
5.4 Global Price, Cost and Gross of Bioengineered Protein Drugs 2010-2015

6 Analysis of Bioengineered Protein Drugs Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity and Production of Bioengineered Protein Drugs 2010-2015
6.2 Production Market Share Analysis of Bioengineered Protein Drugs 2010-2015
6.3 Sales Overview of Bioengineered Protein Drugs 2010-2015
6.4 Supply, Sales and Shortage of Bioengineered Protein Drugs 2010-2015
6.5 Import, Export and Consumption of Bioengineered Protein Drugs 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Bioengineered Protein Drugs 2010-2015

7 Analysis of Bioengineered Protein Drugs Industry Key Manufacturers
7.1 Abbott
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity Production Price Cost Production Value
7.1.4 Contact Information

7.2 Actavis
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity Production Price Cost Production Value
7.2.4 Contact Information

7.3 Alexion Pharmaceuticals
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity Production Price Cost Production Value
7.3.4 Contact Information

7.4 Allergan
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity Production Price Cost Production Value
7.4.4 Contact Information

7.5 Amgen
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity Production Price Cost Production Value
7.5.4 Contact Information

7.6 Baxter Healthcare
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity Production Price Cost Production Value
7.6.4 Contact Information

7.7 Bayer Healthcare Pharmaceuticals
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity Production Price Cost Production Value
7.7.4 Contact Information

7.8 Biogen Idec
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity Production Price Cost Production Value
7.8.4 Contact Information

7.9 Biomarin Pharmaceutical
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity Production Price Cost Production Value
7.9.4 Contact Information

7.10 Bristol-Myers Squibb
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity Production Price Cost Production Value
7.10.4 Contact Information

7.11 Csl Limited
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity Production Price Cost Production Value
7.11.4 Contact Information

7.12 Eli Lilly
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity Production Price Cost Production Value
7.12.4 Contact Information

7.13 Fresenius Kabi Usa
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity Production Price Cost Production Value
7.13.4 Contact Information

7.14 Glaxosmithkline
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity Production Price Cost Production Value
7.14.4 Contact Information

7.15 Hoffman-La-Roche
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity Production Price Cost Production Value
7.15.4 Contact Information

7.16 Hospira
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity Production Price Cost Production Value
7.16.4 Contact Information

7.17 Johnson and Johnson
7.17.1 Company Profile
7.17.2 Product Picture and Specification
7.17.3 Capacity Production Price Cost Production Value
7.17.4 Contact Information

7.18 Lundbeck
7.18.1 Company Profile
7.18.2 Product Picture and Specification
7.18.3 Capacity Production Price Cost Production Value
7.18.4 Contact Information

7.19 Medimmune
7.19.1 Company Profile
7.19.2 Product Picture and Specification
7.19.3 Capacity Production Price Cost Production Value
7.19.4 Contact Information

7.20 Merck and Co.
7.20.1 Company Profile
7.20.2 Product Picture and Specification
7.20.3 Capacity Production Price Cost Production Value
7.20.4 Contact Information

7.21 Merck Kgaa
7.21.1 Company Profile
7.21.2 Product Picture and Specification
7.21.3 Capacity Production Price Cost Production Value
7.21.4 Contact Information

7.22 Mylan
7.22.1 Company Profile
7.22.2 Product Picture and Specification
7.22.3 Capacity Production Price Cost Production Value
7.22.4 Contact Information

7.23 Novartis
7.23.1 Company Profile
7.23.2 Product Picture and Specification
7.23.3 Capacity Production Price Cost Production Value
7.23.4 Contact Information

7.24 Novo Nordisk
7.24.1 Company Profile
7.24.2 Product Picture and Specification
7.24.3 Capacity Production Price Cost Production Value
7.24.4 Contact Information

7.25 Pfizer
7.25.1 Company Profile
7.25.2 Product Picture and Specification
7.25.3 Capacity Production Price Cost Production Value
7.25.4 Contact Information

7.26 Sandoz
7.26.1 Company Profile
7.26.2 Product Picture and Specification
7.26.3 Capacity Production Price Cost Production Value
7.26.4 Contact Information

7.27 Sanofi
7.27.1 Company Profile
7.27.2 Product Picture and Specification
7.27.3 Capacity Production Price Cost Production Value
7.27.4 Contact Information

7.28 Seattle Genetics
7.28.1 Company Profile
7.28.2 Product Picture and Specification
7.28.3 Capacity Production Price Cost Production Value
7.28.4 Contact Information

7.29 Takeda Pharmaceutical U.S.A.
7.29.1 Company Profile
7.29.2 Product Picture and Specification
7.29.3 Capacity Production Price Cost Production Value
7.29.4 Contact Information

7.30 Ucb Company
7.30.1 Company Profile
7.30.2 Product Picture and Specification
7.30.3 Capacity Production Price Cost Production Value
7.30.4 Contact Information

7.31 Viropharma
7.31.1 Company Profile
7.31.2 Product Picture and Specification
7.31.3 Capacity Production Price Cost Production Value
7.31.4 Contact Information

7.32 Vertex Pharmaceuticals
7.32.1 Company Profile
7.32.2 Product Picture and Specification
7.32.3 Capacity Production Price Cost Production Value
7.32.4 Contact Information

7.33 Wockhardt
7.33.1 Company Profile
7.33.2 Product Picture and Specification
7.33.3 Capacity Production Price Cost Production Value
7.33.4 Contact Information

7.34 X-Gen Pharmaceuticals
7.34.1 Company Profile
7.34.2 Product Picture and Specification
7.34.3 Capacity Production Price Cost Production Value
7.34.4 Contact Information

7.35 Zymogenetics
7.35.1 Company Profile
7.35.2 Product Picture and Specification
7.35.3 Capacity Production Price Cost Production Value
7.35.4 Contact Information

8 Price and Gross Margin Analysis
8.1 Analysis of Price, Supply and Consumption
8.1.1 Price Analysis
8.1.2 Supply Analysis
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Bioengineered Protein Drugs Product Types
8.5 Market Share Analysis of Different Bioengineered Protein Drugs Price Levels
8.6 Gross Margin Analysis of Different Bioengineered Protein Drugs Applications

9 Marketing Trader or Distributor Analysis of Bioengineered Protein Drugs
9.1 Marketing Channels Status of Bioengineered Protein Drugs
9.2 Traders or Distributors of Bioengineered Protein Drugs with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Bioengineered Protein Drugs
9.4 Regional Import, Export and Trade Analysis of Bioengineered Protein Drugs

10 Development Trend of Bioengineered Protein Drugs Industry 2015-2020
10.1 Capacity and Production Overview of Bioengineered Protein Drugs 2015-2020
10.2 Production Market Share Analysis of Bioengineered Protein Drugs 2015-2020
10.3 Sales Overview of Bioengineered Protein Drugs 2015-2020
10.4 Supply, Sales, and Shortage of Bioengineered Protein Drugs 2015-2020
10.5 Import, Export and Consumption of Bioengineered Protein Drugs 2015-2020
10.6 Cost, Price, Revenue and Gross Margin of Bioengineered Protein Drugs 2015-2020

11 Industry Chain Suppliers of Bioengineered Protein Drugs with Contact Information
11.1 Major Raw Materials Suppliers of Bioengineered Protein Drugs with Contact Information
11.2 Manufacturing Equipment Suppliers of Bioengineered Protein Drugs with Contact Information
11.3 Major Suppliers of Bioengineered Protein Drugs with Contact Information
11.4 Key Consumers of Bioengineered Protein Drugs with Contact Information
11.5 Supply Chain Relationship Analysis of Bioengineered Protein Drugs

12 New Project Investment Feasibility Analysis of Bioengineered Protein Drugs
12.1 New Project SWOT Analysis of Bioengineered Protein Drugs
12.2 New Project Investment Feasibility Analysis of Bioengineered Protein Drugs

13 Conclusion of the Global Bioengineered Protein Drugs Industry 2015 Market Research Report


List of Tables and Figures
Figure Picture of Bioengineered Protein Drugs
Table Product Specifications of Bioengineered Protein Drugs
Figure Global Sales Market Share of Bioengineered Protein Drugs by Product Types in 2014
Figure Global Sales Market Share of Bioengineered Protein Drugs by Applications in 2014
Figure Industry Chain Structure of Bioengineered Protein Drugs
Table Global Major Bioengineered Protein Drugs Manufacturers
Table Industry Policy of Bioengineered Protein Drugs
Table Industry News List of Bioengineered Protein Drugs
Table Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs in 2014
Figure Manufacturing Process Analysis of Bioengineered Protein Drugs
Table Capacity (K Person-portion) and Commercial Production Date of Global Bioengineered Protein Drugs Key Manufacturers in 2014
Table Manufacturing Plants Distribution of Global Key Bioengineered Protein Drugs Manufacturers in 2014
Table RandD Status and Technology Source of Global Bioengineered Protein Drugs Key Manufacturers in 2014
Table Raw Materials Sources Analysis of Global and China Bioengineered Protein Drugs Key Manufacturers in 2014
Table Global Production of Bioengineered Protein Drugs by Regions 2010-2015 (K Person-portion)
Figure Global Production Market Share of Bioengineered Protein Drugs by Regions in 2010
Figure Global Production Market Share of Bioengineered Protein Drugs by Regions in 2011
Figure Global Production Market Share of Bioengineered Protein Drugs by Regions in 2012
Figure Global Production Market Share of Bioengineered Protein Drugs by Regions in 2013
Figure Global Production Market Share of Bioengineered Protein Drugs by Regions in 2014
Figure Global Production Market Share of Bioengineered Protein Drugs by Regions in 2015
Figure Global Production Market Share of Bioengineered Protein Drugs by Technology in 2010
Figure Global Production Market Share of Bioengineered Protein Drugs by Technology in 2011
Figure Global Production Market Share of Bioengineered Protein Drugs by Technology in 2012
Figure Global Production Market Share of Bioengineered Protein Drugs by Technology in 2013
Figure Global Production Market Share of Bioengineered Protein Drugs by Technology in 2014
Figure Global Production Market Share of Bioengineered Protein Drugs by Technology in 2015
Figure Global Production Market Share of Bioengineered Protein Drugs by Applications in 2010
Figure Global Production Market Share of Bioengineered Protein Drugs by Applications in 2011
Figure Global Production Market Share of Bioengineered Protein Drugs by Applications in 2012
Figure Global Production Market Share of Bioengineered Protein Drugs by Applications in 2013
Figure Global Production Market Share of Bioengineered Protein Drugs by Applications in 2014
Figure Global Production Market Share of Bioengineered Protein Drugs by Applications in 2015
Figure Price Comparison of Global Bioengineered Protein Drugs Key Manufacturers in 2015 (USD/Person-portion)
Table US Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Bioengineered Protein Drugs 2010-2015
Table EU Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Bioengineered Protein Drugs 2010-2015
Table Japan Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Bioengineered Protein Drugs 2010-2015
Table China Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Bioengineered Protein Drugs 2010-2015
Table US Supply, Import, Export and Consumption of Bioengineered Protein Drugs 2010-2015 (K Person-portion)
Table EU Supply, Import, Export and Consumption of Bioengineered Protein Drugs 2010-2015 (K Person-portion)
Table Japan Supply, Import, Export and Consumption of Bioengineered Protein Drugs 2010-2015 (K Person-portion)
Table China Supply, Import, Export and Consumption of Bioengineered Protein Drugs 2010-2015 (K Person-portion)
Table Global Sales of Bioengineered Protein Drugs by Regions (US, EU, China, Japan, etc.) 2010-2015 (K Person-portion)
Figure Global Sales of Bioengineered Protein Drugs by Regions (EU, China, Japan, etc.) in 2010 (K Person-portion)
Figure Global Sales of Bioengineered Protein Drugs by Regions (EU, China, Japan, etc.) in 2011 (K Person-portion)
Figure Global Sales of Bioengineered Protein Drugs by Regions (EU, China, Japan, etc.) in 2012 (K Person-portion)
Figure Global Sales of Bioengineered Protein Drugs by Regions (EU, China, Japan, etc.) in 2013 (K Person-portion)
Figure Global Sales of Bioengineered Protein Drugs by Regions (EU, China, Japan, etc.) in 2014 (K Person-portion)
Figure Global Sales of Bioengineered Protein Drugs by Regions (EU, China, Japan, etc.) in 2015 (K Person-portion)
Table Global Revenue of Bioengineered Protein Drugs by Regions (US, EU, China, Japan, etc.) 2010-2015 (M USD)
Figure Global Revenue of Bioengineered Protein Drugs by Regions (US, EU, China, Japan, etc.) in 2010 (M USD)
Figure Global Revenue of Bioengineered Protein Drugs by Regions (US, EU, China, Japan, etc.) in 2011 (M USD)
Figure Global Revenue of Bioengineered Protein Drugs by Regions (US, EU, China, Japan, etc.) in 2012 (M USD)
Figure Global Revenue of Bioengineered Protein Drugs by Regions (US, EU, China, Japan, etc.) in 2013 (M USD)
Figure Global Revenue of Bioengineered Protein Drugs by Regions (US, EU, China, Japan, etc.) in 2014 (M USD)
Figure Global Revenue of Bioengineered Protein Drugs by Regions (US, EU, China, Japan, etc.) in 2015 (M USD)
Table Sale Price of Bioengineered Protein Drugs by Regions (US, EU, China, Japan, etc.) 2010-2015 (USD/Person-portion)
Figure Global Price Analysis of Bioengineered Protein Drugs 2010-2015 (USD/Person-portion)
Figure Global Cost Analysis of Bioengineered Protein Drugs 2010-2015 (USD/Person-portion)
Figure Global Gross Analysis of Bioengineered Protein Drugs 2010-2015
Table Global and Major Manufacturers Capacity of Bioengineered Protein Drugs 2010-2015 (K Person-portion)
Table Global Capacity Market Share of Major Bioengineered Protein Drugs Manufacturers 2010-2015
Table Global and Major Manufacturers Production of Bioengineered Protein Drugs 2010-2015 (K Person-portion)
Table Global Production Market Share of Major Bioengineered Protein Drugs Manufacturers 2010-2015
Figure Global Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Bioengineered Protein Drugs 2010-2015
Figure Global Capacity Utilization Rate of Bioengineered Protein Drugs 2010-2015
Table Global and Major Manufacturers Revenue of Bioengineered Protein Drugs 2010-2015 (M USD)
Table Global Revenue Market Share of Major Bioengineered Protein Drugs Manufacturers 2010-2015
Figure Global Revenue (M USD) and Growth Rate of Bioengineered Protein Drugs 2010-2015
Table China and Major Manufacturers Capacity of Bioengineered Protein Drugs 2010-2015 (K Person-portion)
Table Capacity Market Share of China Major Bioengineered Protein Drugs Manufacturers 2010-2015
Table China and Major Manufacturers Production 2010-2015 (K Person-portion)
Table Production Market Share of China Major Manufacturers 2010-2015
Figure China Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Bioengineered Protein Drugs 2010-2015
Figure China Capacity Utilization Rate of Bioengineered Protein Drugs 2010-2015
Table China and Major Manufacturers Revenue of Bioengineered Protein Drugs 2010-2015 (M USD)
Table Revenue Market Share of China Major Manufacturers 2010-2015
Figure China Revenue (M USD) and Growth Rate of Bioengineered Protein Drugs 2010-2015
Figure Global Production Market Share of Major Bioengineered Protein Drugs Manufacturers in 2010
Figure Global Production Market Share of Major Bioengineered Protein Drugs Manufacturers in 2011
Figure Global Production Market Share of Major Bioengineered Protein Drugs Manufacturers in 2012
Figure Global Production Market Share of Major Bioengineered Protein Drugs Manufacturers in 2013
Figure Global Production Market Share of Major Bioengineered Protein Drugs Manufacturers in 2014
Figure Global Production Market Share of Major Bioengineered Protein Drugs Manufacturers in 2015
Figure China Production Market Share of Major Bioengineered Protein Drugs Manufacturers in 2010
Figure China Production Market Share of Major Bioengineered Protein Drugs Manufacturers in 2011
Figure China Production Market Share of Major Bioengineered Protein Drugs Manufacturers in 2012
Figure China Production Market Share of Major Bioengineered Protein Drugs Manufacturers in 2013
Figure China Production Market Share of Major Bioengineered Protein Drugs Manufacturers in 2014
Figure China Production Market Share of Major Bioengineered Protein Drugs Manufacturers in 2015
Figure Global Sales (K Person-portion) and Growth Rate of Bioengineered Protein Drugs 2010-2015
Figure China Sales (K Person-portion) and Growth Rate of Bioengineered Protein Drugs 2010-2015
Table Global Supply, Sales and Shortage of Bioengineered Protein Drugs 2010-2015 (K Person-portion)
Table China Supply, Sales and Shortage of Bioengineered Protein Drugs 2010-2015 (K Person-portion)
Table China Import, Export and Consumption of Bioengineered Protein Drugs 2010-2015 (K Person-portion)
Table Price of Global Bioengineered Protein Drugs Major Manufacturers 2010-2015 (USD/Person-portion)
Figure Price Comparison by Global Major Bioengineered Protein Drugs Manufacturers in 2014 (USD/Person-portion)
Table Gross Margin of Global Bioengineered Protein Drugs Major Manufacturers 2010-2015
Figure Gross Margin of Global Bioengineered Protein Drugs Major Manufacturers in 2014
Table Global and Major Manufacturers Revenue of Bioengineered Protein Drugs 2010-2015 (M USD)
Table Global Revenue Market Share of Major Bioengineered Protein Drugs Manufacturers 2010-2015
Figure Global Revenue Market Share of Major Bioengineered Protein Drugs Manufacturers in 2011
Figure Global Revenue Market Share of Major Bioengineered Protein Drugs Manufacturers in 2012
Figure Global Revenue Market Share of Major Bioengineered Protein Drugs Manufacturers in 2013
Figure Global Revenue Market Share of Major Bioengineered Protein Drugs Manufacturers in 2014
Figure Global Revenue Market Share of Major Bioengineered Protein Drugs Manufacturers in 2015
Table China and Major Manufacturers of Bioengineered Protein Drugs 2010-2015 (M USD)
Table Revenue Market Share of China Bioengineered Protein Drugs Major Manufacturers 2010-2015
Table Global Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Revenue (M USD) and Gross Margin of Bioengineered Protein Drugs 2010-2015
Table China Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Revenue (M USD) and Gross Margin of Bioengineered Protein Drugs 2010-2015
Figure Abbott Bioengineered Protein Drugs Product Picture
Table Abbott Bioengineered Protein Drugs Product Specification
Table 2010-2015 Abbott Bioengineered Protein Drugs Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Abbott Bioengineered Protein Drugs Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Abbott Bioengineered Protein Drugs Product Production Global Market Share
Figure Actavis Bioengineered Protein Drugs Product Picture
Table Actavis Bioengineered Protein Drugs Product Specification
Table 2010-2015 Actavis Bioengineered Protein Drugs Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Actavis Bioengineered Protein Drugs Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Actavis Bioengineered Protein Drugs Product Production Global Market Share
Figure Alexion Pharmaceuticals Bioengineered Protein Drugs Product Picture
Table Alexion Pharmaceuticals Bioengineered Protein Drugs Product Specification
Table 2010-2015 Alexion Pharmaceuticals Bioengineered Protein Drugs Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Alexion Pharmaceuticals Bioengineered Protein Drugs Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Alexion Pharmaceuticals Bioengineered Protein Drugs Product Production Global Market Share
Figure Allergan Bioengineered Protein Drugs Product Picture
Table Allergan Bioengineered Protein Drugs Product Specification
Table 2010-2015 Allergan Bioengineered Protein Drugs Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Allergan Bioengineered Protein Drugs Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Allergan Bioengineered Protein Drugs Product Production Global Market Share
Figure Amgen Bioengineered Protein Drugs Product Picture
Table Amgen Bioengineered Protein Drugs Product Specification
Table 2010-2015 Amgen Bioengineered Protein Drugs Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Amgen Bioengineered Protein Drugs Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Amgen Bioengineered Protein Drugs Product Production Global Market Share
Figure Baxter Healthcare Bioengineered Protein Drugs Product Picture
Table Baxter Healthcare Bioengineered Protein Drugs Product Specification
Table 2010-2015 Baxter Healthcare Bioengineered Protein Drugs Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Baxter Healthcare Bioengineered Protein Drugs Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Baxter Healthcare Bioengineered Protein Drugs Product Production Global Market Share
Figure Bayer Healthcare Pharmaceuticals Bioengineered Protein Drugs Product Picture
Table Bayer Healthcare Pharmaceuticals Bioengineered Protein Drugs Product Specification
Table 2010-2015 Bayer Healthcare Pharmaceuticals Bioengineered Protein Drugs Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Bayer Healthcare Pharmaceuticals Bioengineered Protein Drugs Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Bayer Healthcare Pharmaceuticals Bioengineered Protein Drugs Product Production Global Market Share
Figure Biogen Idec Bioengineered Protein Drugs Product Picture
Table Biogen Idec Bioengineered Protein Drugs Product Specification
Table 2010-2015 Biogen Idec Bioengineered Protein Drugs Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Biogen Idec Bioengineered Protein Drugs Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Biogen Idec Bioengineered Protein Drugs Product Production Global Market Share
Figure Biomarin Pharmaceutical Bioengineered Protein Drugs Product Picture
Table Biomarin Pharmaceutical Bioengineered Protein Drugs Product Specification
Table 2010-2015 Biomarin Pharmaceutical Bioengineered Protein Drugs Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Biomarin Pharmaceutical Bioengineered Protein Drugs Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Biomarin Pharmaceutical Bioengineered Protein Drugs Product Production Global Market Share
Figure Bristol-Myers Squibb Bioengineered Protein Drugs Product Picture
Table Bristol-Myers Squibb Bioengineered Protein Drugs Product Specification
Table 2010-2015 Bristol-Myers Squibb Bioengineered Protein Drugs Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Bristol-Myers Squibb Bioengineered Protein Drugs Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Bristol-Myers Squibb Bioengineered Protein Drugs Product Production Global Market Share
Figure Csl Limited Bioengineered Protein Drugs Product Picture
Table Csl Limited Bioengineered Protein Drugs Product Specification
Table 2010-2015 Csl Limited Bioengineered Protein Drugs Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Csl Limited Bioengineered Protein Drugs Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Csl Limited Bioengineered Protein Drugs Product Production Global Market Share
Figure Eli Lilly Bioengineered Protein Drugs Product Picture
Table Eli Lilly Bioengineered Protein Drugs Product Specification
Table 2010-2015 Eli Lilly Bioengineered Protein Drugs Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Eli Lilly Bioengineered Protein Drugs Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Eli Lilly Bioengineered Protein Drugs Product Production Global Market Share
Figure Fresenius Kabi Usa Bioengineered Protein Drugs Product Picture
Table Fresenius Kabi Usa Bioengineered Protein Drugs Product Specification
Table 2010-2015 Fresenius Kabi Usa Bioengineered Protein Drugs Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Fresenius Kabi Usa Bioengineered Protein Drugs Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Fresenius Kabi Usa Bioengineered Protein Drugs Product Production Global Market Share
Figure Glaxosmithkline Bioengineered Protein Drugs Product Picture
Table Glaxosmithkline Bioengineered Protein Drugs Product Specification
Table 2010-2015 Glaxosmithkline Bioengineered Protein Drugs Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Glaxosmithkline Bioengineered Protein Drugs Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Glaxosmithkline Bioengineered Protein Drugs Product Production Global Market Share
Figure Hoffman-La-Roche Bioengineered Protein Drugs Product Picture
Table Hoffman-La-Roche Bioengineered Protein Drugs Product Specification
Table 2010-2015 Hoffman-La-Roche Bioengineered Protein Drugs Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Hoffman-La-Roche Bioengineered Protein Drugs Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Hoffman-La-Roche Bioengineered Protein Drugs Product Production Global Market Share
Figure Hospira Bioengineered Protein Drugs Product Picture
Table Hospira Bioengineered Protein Drugs Product Specification
Table 2010-2015 Hospira Bioengineered Protein Drugs Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Hospira Bioengineered Protein Drugs Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Hospira Bioengineered Protein Drugs Product Production Global Market Share
Figure Johnson and Johnson Bioengineered Protein Drugs Product Picture
Table Johnson and Johnson Bioengineered Protein Drugs Product Specification
Table 2010-2015 Johnson and Johnson Bioengineered Protein Drugs Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Johnson and Johnson Bioengineered Protein Drugs Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Johnson and Johnson Bioengineered Protein Drugs Product Production Global Market Share
Figure Lundbeck Bioengineered Protein Drugs Product Picture
Table Lundbeck Bioengineered Protein Drugs Product Specification
Table 2010-2015 Lundbeck Bioengineered Protein Drugs Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Lundbeck Bioeng

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PEGylated Proteins Market by Consumables, Services, Protein Type, Application, End-User - Global Forecast to 2021

PEGylated Proteins Market by Consumables, Services, Protein Type, Application, End-User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The global PEGylated proteins market is expected to USD 1,137.8 million by 2021 from USD 690.6 million in 2016, at a CAGR of 10.5% between 2016 and 2021. The growth of this market is mainly driven by increase ...

Protein Labeling Market by Product, Labeling Method, Application, & Region - Global Forecast to 2020

Protein Labeling Market by Product, Labeling Method, Application, & Region - Global Forecast to 2020

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global protein labeling market is expected to reach USD 1,894.5 million by 2020 from USD 1,089.5 million in 2015, at a CAGR of 11.7% from 2015 to 2020. On the basis of products, the protein labeling ...

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Globally, development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar, increasing government initiative across the globe, ...

Global Pea Protein Market

October 2016 $ 4250

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.